Contract 75D30121P10611
Twist Bioscience Corporation · Department Of Health And Human Services · June 25, 2024
Twist Bioscience Corporation was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on June 25, 2024 for $578,000 (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in South San Francisco, CA. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $578,000.
Contract details
- PIID
- 75D30121P10611
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- South San Francisco, CA
- First action
- June 25, 2024
Description
SC2 POSITIVE CONTROL SYNTHETIC RNA CONTROL MATERIAL
Modification timeline
-
June 25, 2024Mod P00002 · Other Administrative Action$540.1K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30121P10611?
Contract 75D30121P10611 is a federal contract awarded to Twist Bioscience Corporation by Department Of Health And Human Services on June 25, 2024 for $578,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75D30121P10611?
Twist Bioscience Corporation won contract 75D30121P10611 from Department Of Health And Human Services.
How much is contract 75D30121P10611 worth?
Contract 75D30121P10611 has obligated $0 to date but carries a potential ceiling of $578,000 if fully funded and all options are exercised.